脑胶质瘤诊疗规范(2018年版)

2018-12-13 中华人民共和国国家卫生健康委员会 中华人民共和国国家卫生健康委员会官网

脑胶质瘤治疗需要神经外科、神经影像科、放射治疗科、神经肿瘤科、病理科和神经康复科等多学科合作,遵循循证医学原则,采取个体化综合治疗,优化和规范治疗方案,以期达到最大治疗效益,尽可能延长患者的无进展生存期(PFS) 和总生存期(OS),提高生存质量。为使患者获得最优化的综合治疗,医师需要对患者进行密切随访观察,定期影像学复查,兼顾考虑患者的日常生活、社会和家庭活动、营养支持、疼痛控制、康复治疗和心理

中文标题:

脑胶质瘤诊疗规范(2018年版)

发布日期:

2018-12-13

简要介绍:

脑胶质瘤治疗需要神经外科、神经影像科、放射治疗科、神经肿瘤科、病理科和神经康复科等多学科合作,遵循循证医学原则,采取个体化综合治疗,优化和规范治疗方案,以期达到最大治疗效益,尽可能延长患者的无进展生存期(PFS) 和总生存期(OS),提高生存质量。为使患者获得最优化的综合治疗,医师需要对患者进行密切随访观察,定期影像学复查,兼顾考虑患者的日常生活、社会和家庭活动、营养支持、疼痛控制、康复治疗和心理调控等诸多问题。

拓展指南:脑胶质瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=脑胶质瘤诊疗规范(2018年版))] GetToolGuiderByIdResponse(projectId=1, id=223d81c00168017a, title=脑胶质瘤诊疗规范(2018年版), enTitle=, guiderFrom=中华人民共和国国家卫生健康委员会官网, authorId=null, author=, summary=脑胶质瘤治疗需要神经外科、神经影像科、放射治疗科、神经肿瘤科、病理科和神经康复科等多学科合作,遵循循证医学原则,采取个体化综合治疗,优化和规范治疗方案,以期达到最大治疗效益,尽可能延长患者的无进展生存期(PFS) 和总生存期(OS),提高生存质量。为使患者获得最优化的综合治疗,医师需要对患者进行密切随访观察,定期影像学复查,兼顾考虑患者的日常生活、社会和家庭活动、营养支持、疼痛控制、康复治疗和心理, cover=, journalId=null, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Dec 13 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>脑胶质瘤治疗需要神经外科、神经影像科、放射治疗科、神经肿瘤科、病理科和神经康复科等多学科合作,遵循循证医学原则,采取个体化综合治疗,优化和规范治疗方案,以期达到最大治疗效益,尽可能延长患者的无进展生存期(PFS) 和总生存期(OS),提高生存质量。为使患者获得最优化的综合治疗,医师需要对患者进行密切随访观察,定期影像学复查,兼顾考虑患者的日常生活、社会和家庭活动、营养支持、疼痛控制、康复治疗和心理调控等诸多问题。</div> <div><br> </div>拓展指南:<strong>与<font color=red>脑胶质瘤</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=6b13c1c0010e75b8" title="2014 中国脑胶质瘤分子诊疗指南" target=_blank>2014 中国脑胶质瘤分子诊疗指南</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%84%91%E8%83%B6%E8%B4%A8%E7%98%A4" target=_blank>有关脑胶质瘤更多指南</a></ul>, tagList=[TagDto(tagId=8810, tagName=脑胶质瘤), TagDto(tagId=540, tagName=诊疗规范)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=18740, appHits=988, showAppHits=37, pcHits=10415, showPcHits=10424, likes=143, shares=54, comments=10, approvalStatus=1, publishedTime=Wed Dec 26 21:23:50 CST 2018, publishedTimeString=2018-12-13, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Dec 26 21:23:50 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:33:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=脑胶质瘤诊疗规范(2018年版))])
脑胶质瘤诊疗规范(2018年版)
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1209352, encodeId=a1e6120935267, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220313/1fccd8869aca4c2bbabb274c6aada833/8cdb5c5762b54b208703fcac43dcca47.jpg, createdBy=872f5678021, createdName=jing0309, createdTime=Thu Apr 07 20:37:05 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191341, encodeId=4997119134177, content=这个好,赞一个!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c1e5326845, createdName=148be7fam17暂无昵称, createdTime=Wed Feb 09 09:12:53 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187846, encodeId=5a46118e84643, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f82d6481868, createdName=ms4000000282771868, createdTime=Mon Jan 24 22:16:51 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995882, encodeId=637c995882ed, content=怎么赚取积分啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91445540576, createdName=魏十月, createdTime=Sat Jul 03 20:41:37 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968586, encodeId=6460968586d8, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9f5507922, createdName=samtang, createdTime=Wed May 26 11:20:19 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
    2022-04-07 jing0309

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1209352, encodeId=a1e6120935267, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220313/1fccd8869aca4c2bbabb274c6aada833/8cdb5c5762b54b208703fcac43dcca47.jpg, createdBy=872f5678021, createdName=jing0309, createdTime=Thu Apr 07 20:37:05 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191341, encodeId=4997119134177, content=这个好,赞一个!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c1e5326845, createdName=148be7fam17暂无昵称, createdTime=Wed Feb 09 09:12:53 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187846, encodeId=5a46118e84643, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f82d6481868, createdName=ms4000000282771868, createdTime=Mon Jan 24 22:16:51 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995882, encodeId=637c995882ed, content=怎么赚取积分啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91445540576, createdName=魏十月, createdTime=Sat Jul 03 20:41:37 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968586, encodeId=6460968586d8, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9f5507922, createdName=samtang, createdTime=Wed May 26 11:20:19 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
    2022-02-09 148be7fam17暂无昵称

    这个好,赞一个!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1209352, encodeId=a1e6120935267, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220313/1fccd8869aca4c2bbabb274c6aada833/8cdb5c5762b54b208703fcac43dcca47.jpg, createdBy=872f5678021, createdName=jing0309, createdTime=Thu Apr 07 20:37:05 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191341, encodeId=4997119134177, content=这个好,赞一个!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c1e5326845, createdName=148be7fam17暂无昵称, createdTime=Wed Feb 09 09:12:53 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187846, encodeId=5a46118e84643, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f82d6481868, createdName=ms4000000282771868, createdTime=Mon Jan 24 22:16:51 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995882, encodeId=637c995882ed, content=怎么赚取积分啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91445540576, createdName=魏十月, createdTime=Sat Jul 03 20:41:37 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968586, encodeId=6460968586d8, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9f5507922, createdName=samtang, createdTime=Wed May 26 11:20:19 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
    2022-01-24 ms4000000282771868

    好好好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1209352, encodeId=a1e6120935267, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220313/1fccd8869aca4c2bbabb274c6aada833/8cdb5c5762b54b208703fcac43dcca47.jpg, createdBy=872f5678021, createdName=jing0309, createdTime=Thu Apr 07 20:37:05 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191341, encodeId=4997119134177, content=这个好,赞一个!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c1e5326845, createdName=148be7fam17暂无昵称, createdTime=Wed Feb 09 09:12:53 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187846, encodeId=5a46118e84643, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f82d6481868, createdName=ms4000000282771868, createdTime=Mon Jan 24 22:16:51 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995882, encodeId=637c995882ed, content=怎么赚取积分啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91445540576, createdName=魏十月, createdTime=Sat Jul 03 20:41:37 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968586, encodeId=6460968586d8, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9f5507922, createdName=samtang, createdTime=Wed May 26 11:20:19 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
    2021-07-03 魏十月

    怎么赚取积分啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1209352, encodeId=a1e6120935267, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220313/1fccd8869aca4c2bbabb274c6aada833/8cdb5c5762b54b208703fcac43dcca47.jpg, createdBy=872f5678021, createdName=jing0309, createdTime=Thu Apr 07 20:37:05 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191341, encodeId=4997119134177, content=这个好,赞一个!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c1e5326845, createdName=148be7fam17暂无昵称, createdTime=Wed Feb 09 09:12:53 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187846, encodeId=5a46118e84643, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f82d6481868, createdName=ms4000000282771868, createdTime=Mon Jan 24 22:16:51 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995882, encodeId=637c995882ed, content=怎么赚取积分啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91445540576, createdName=魏十月, createdTime=Sat Jul 03 20:41:37 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968586, encodeId=6460968586d8, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d9f5507922, createdName=samtang, createdTime=Wed May 26 11:20:19 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
    2021-05-26 samtang

    这个好

    0